Sign inJoin waitlistJoin the waitlist

Bryan Schneider

Associate Dean for Clinical Trials · Indiana University School of Medicine

Credentials: · · ·

History

Indiana University School of Medicine
Present
Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Indiana University School of Medicine
2002–2004
Indiana University School of Medicine
1999–2002
Indiana University School of Medicine
1995–1999

Research

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline
Review · Journal of Clinical Oncology · 2014 · 905 citations
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Journal of Clinical Oncology · 2020 · 869 citations
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 560 citations

Kathy Miller
39 papers
George Sledge
28 papers
Anna Storniolo
20 papers
CD
Chau Dang
16 papers
Tarah Ballinger
16 papers · 1 as a fellow
Hope Rugo
13 papers
Ann Partridge
12 papers
Nawal Kassem
12 papers · 7 as a resident
Joseph Sparano
11 papers
Eric Winer
10 papers
Gregory Riedlinger
10 papers
Harold Burstein
10 papers

Grants

Targeting HER2-Low Breast Cancer with 17p Loss
National Cancer Institute · R01
PI · $1.6M · Indiana University Indianapolis
2016–2026
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
National Cancer Institute · R01
Contact PI · $962.1K · Indiana University Indianapolis
2011–2015
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $376K · Indiana University Indianapolis
2005–2008

Clinical trials

Evaluating Disparities in Precision Oncology
Principal investigator · Recruiting
Indiana University
2024–2028
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
Principal investigator · Terminated · Phase 2
Bryan Schneider, MD
2021–2024
Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy
Principal investigator · Terminated
Bryan Schneider
2018
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Principal investigator · Completed
ECOG-ACRIN Cancer Research Group
2011